|
시장보고서
상품코드
2050662
투석기 시장 : 유형별, 사용 형태별, 막 재료별, 멸균 방법별, 최종사용자별, 지역별Dialyzer Market, By Type, By Usage Type, By Membrane Material, By Sterilization Method, By End User, By Geography |
||||||
투석기 시장은 2026년에 46억 1,000만 달러로 추정되고 있으며, 2033년까지 73억 5,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 6.9%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 46억 1,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 6.90% | 2033년 시장 규모 예측 : | 73억 5,000만 달러 |
세계 투석기 시장은 신장대체요법 생태계에서 매우 중요한 요소이며, 전 세계 혈액투석 치료를 지원하는 기반 기술이 되고 있습니다. 인공신장이라고도 불리는 투석기는 급성 또는 만성 신부전 환자의 혈액에서 노폐물, 여분의 수분, 독소를 걸러내는 필수적인 기능을 수행하는 첨단 의료기기입니다.
이러한 반투과성 멤브레인 기반 시스템은 건강한 신장이 자연적으로 수행하는 확산 및 한외여과 과정을 촉진하여 생명 유지를 위해 투석 치료를 필요로 하는 수백만 명의 환자에게 필수적인 존재가 되었습니다. 이 시장에는 고 플럭스, 저 플럭스, 단백질 누출 투석기 등 특정 환자의 필요와 임상 요구 사항을 충족하도록 설계된 다양한 유형의 투석기가 포함되어 있습니다. 말기 신장 질환, 당뇨병성 신증, 고혈압으로 인한 신장 합병증의 유병률이 증가함에 따라 첨단 투석기 기술에 대한 수요는 전 세계에서 급증하고 있습니다. 시장 환경은 환자의 치료 결과를 최적화하고 치료 합병증과 의료 비용을 줄이면서 환자의 치료 결과를 최적화해야 한다는 요구에 힘입어 멤브레인 소재의 지속적인 혁신, 생체적합성 향상, 효율성 향상으로 특징지어집니다.
시장 역학
세계의 투석기 시장은 주로 당뇨병, 고혈압, 고령화 진행으로 인한 만성 신장 질환(CKD) 및 말기 신부전(ESRD)의 유병률 증가 등 몇 가지 강력한 시장 촉진요인에 의해 주도되고 있습니다. 신장 질환의 조기 진단과 치료에 대한 인식이 높아진 데다 신흥 국가의 의료 인프라가 확충되면서 시장 성장에 큰 힘을 보태고 있습니다. 투석기 멤브레인의 기술 발전은 생체적합성 향상과 클리어런스율 향상을 동반한 고 플럭스 및 초고 플럭스 투석기 개발 등 투석기 멤브레인의 기술적 진보를 통해 시장 확대를 더욱 촉진하고 있습니다.
투석에 대한 접근성을 높이기 위한 정부의 노력과 신장 대체요법을 지원하는 상환 정책은 시장 성장에 큰 기여를 하고 있습니다. 그러나 시장에는 눈에 띄는 제약도 존재합니다. 투석 치료 및 장비의 고비용은 저소득 지역의 접근성을 제한하고, 의료 시스템에 경제적 부담을 주고 있습니다. 투석기 승인을 위한 엄격한 규제 요건과 품질관리 조치는 신제품 개발 비용과 시장 출시 기간을 증가시킵니다. 또한 감염, 심혈관 질환, 막 관련 부작용 등 투석 시술에 따른 합병증 위험이 시장 성장에 걸림돌로 작용하고 있습니다. 이러한 제약에도 불구하고 휴대가 간편하고 사용하기 쉬운 투석기 시스템을 필요로 하는 재택 투석 솔루션에 대한 수요가 증가함에 따라 큰 성장 기회가 창출되고 있습니다. 개발도상국에서의 의료관광 산업의 확대는 시장 관계자들에게 비용 효율적인 지역에 제조시설과 유통망을 구축할 수 있는 기회로 작용하고 있습니다. 또한 맞춤형 의료와 개별 임상 파라미터에 따른 환자별 투석기 선택에 대한 관심이 높아지고 있는 것은 혁신적인 제품 개발 및 시장 차별화를 위한 큰 성장 가능성을 보여주고 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 매출기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 연구는 글로벌 투석기 시장의 주요 기업 개요을 다음과 같은 매개 변수를 기반으로 작성되었습니다. : 회사 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 세계의 투석기 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 투석기 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 투석기 시장 : 유형별, 2021-2033년
제5장 세계의 투석기 시장 : 사용 형태별, 2021-2033년
제6장 세계의 투석기 시장 : 막 재료별, 2021-2033년
제7장 세계의 투석기 시장 : 멸균 방법별, 2021-2033년
제8장 세계의 투석기 시장 : 최종사용자별, 2021-2033년
제9장 세계의 투석기 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
KSA 26.06.10Dialyzer Market is estimated to be valued at USD 4.61 Bn in 2026 and is expected to reach USD 7.35 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4.61 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.90% | 2033 Value Projection: | USD 7.35 Bn |
The global dialyzer market represents a critical component of the renal replacement therapy ecosystem, serving as the cornerstone technology for hemodialysis treatment worldwide. Dialyzers, also known as artificial kidneys, are sophisticated medical devices that perform the essential function of filtering waste products, excess water, and toxins from the blood of patients suffering from acute or chronic kidney failure.
These semi-permeable membrane-based systems facilitate the diffusion and ultrafiltration processes that healthy kidneys naturally perform, making them indispensable for millions of patients requiring life-sustaining dialysis treatment. The market encompasses various types of dialyzers, including high-flux, low-flux, and protein-leaking dialyzers, each designed to meet specific patient needs and clinical requirements. With the increasing prevalence of end-stage renal disease, diabetes-related nephropathy, and hypertension-induced kidney complications, the demand for advanced dialyzer technologies continues to surge globally. The market landscape is characterized by continuous innovation in membrane materials, biocompatibility enhancements, and efficiency improvements, driven by the need to optimize patient outcomes while reducing treatment-related complications and healthcare costs.
Market Dynamics
The global dialyzer market is propelled by several compelling drivers, primarily the escalating prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, attributed to the rising incidence of diabetes, hypertension, and aging populations. The increasing awareness about early diagnosis and treatment of kidney disorders, coupled with expanding healthcare infrastructure in emerging economies, significantly drives market growth. Technological advancements in dialyzer membranes, including the development of high-flux and super high-flux dialyzers with enhanced biocompatibility and improved clearance rates, further stimulate market expansion.
Government initiatives promoting dialysis accessibility and reimbursement policies supporting renal replacement therapies contribute substantially to market growth. However, the market faces notable restraints including the high cost of dialysis treatment and equipment, which limits accessibility in low-income regions and creates economic burden for healthcare systems. Stringent regulatory requirements for dialyzer approval and quality control measures increase development costs and time-to-market for new products. Additionally, the risk of complications associated with dialysis procedures, including infection, cardiovascular events, and membrane-related adverse reactions, poses challenges to market growth. Despite these constraints, significant opportunities emerge from the growing demand for home dialysis solutions, which require portable and user-friendly dialyzer systems. The expanding medical tourism industry in developing countries presents lucrative opportunities for market players to establish manufacturing facilities and distribution networks in cost-effective regions. Furthermore, the increasing focus on personalized medicine and patient-specific dialyzer selection based on individual clinical parameters offers substantial growth potential for innovative product development and market differentiation.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global dialyzer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Asahi"¯Kasei Corporation, B."¯Braun Melsungen AG, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, Nikkiso Co., Ltd., Toray Industries, Inc., JMS Co., Ltd., Kawasumi Laboratories, Inc., Medica S.p.A., Shandong Weigao Group Medical Polymer Co., Ltd., Allmed Medical Care Holdings Limited, Dialife SA, Farmasol (company), and WEGO Group
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global dialyzer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dialyzer market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2021 - 2033)
- High"'flux
- Low"'flux
- Medium cut"'off
- Usage Type Insights (Revenue, USD Bn, 2021 - 2033)
- Disposable (single"'use)
- Reusable
- Membrane Material Insights (Revenue, USD Bn, 2021 - 2033)
- Cellulose"'based
- Modified/substituted cellulose
- Synthetic polymer
- PMMA/Other specialty materials
- Sterilization Method Insights (Revenue, USD Bn, 2021 - 2033)
- Steam Sterilization
- Gamma Radiation Sterilization
- Ethylene Oxide (ETO) Sterilization
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals and"¯clinics
- Dialysis centres
- Home care/home dialysis
- Ambulatory surgical centres
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Asahi"¯Kasei Corporation
- "¯Braun Melsungen AG
- Baxter International Inc.
- Fresenius Medical Care AG & Co. KGaA
- Nipro Corporation
- Nikkiso Co., Ltd.
- Toray Industries, Inc.
- JMS Co., Ltd.
- Kawasumi Laboratories, Inc.
- Medica S.p.A.
- Shandong Weigao Group Medical Polymer Co., Ltd.
- Allmed Medical Care Holdings Limited
- Dialife SA
- Farmasol (company)
- WEGO Group
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Dialyzer Market, By Type
- Global Dialyzer Market, By Usage Type
- Global Dialyzer Market, By Membrane Material
- Global Dialyzer Market, By Sterilization Method
- Global Dialyzer Market, By End User
- Global Dialyzer Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Dialyzer Market, By Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- High"'flux
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Low"'flux
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Medium cut"'off
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Dialyzer Market, By Usage Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Disposable (single"'use)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Reusable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Dialyzer Market, By Membrane Material, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cellulose"'based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Modified/substituted cellulose
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Synthetic polymer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- PMMA/Other specialty materials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Dialyzer Market, By Sterilization Method, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Steam Sterilization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Gamma Radiation Sterilization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ethylene Oxide (ETO) Sterilization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Dialyzer Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals and"¯clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Dialysis centres
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home care/home dialysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory surgical centres
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Dialyzer Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Membrane Material, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sterilization Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Membrane Material, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sterilization Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Membrane Material, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sterilization Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Membrane Material, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sterilization Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Membrane Material, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sterilization Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Usage Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Membrane Material, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sterilization Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Asahi"¯Kasei Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- "¯Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fresenius Medical Care AG & Co. KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nipro Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nikkiso Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Toray Industries, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- JMS Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Kawasumi Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medica S.p.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Shandong Weigao Group Medical Polymer Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Allmed Medical Care Holdings Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dialife SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Farmasol (company)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- WEGO Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
